A PD Solution to Protect Peritoneal Membranes

PD-protec® by Zytoprotec, which now has FDA orphan drug status, is in Phase III trials among 300 patients in the US and Europe. The product aims to reduce PD complications such as peritonitis and membrane failure.

Read the full article » | Posted 01-11-2018

Related Articles

• Wearable PD Device to Purify and Reuse Dialysate Posted 04-23-2025
• Understand Sorbent Dialysis in 8 Minutes Posted 03-13-2025
• Kidney Research UK Invests in a MicroBioSensor to Detect Peritonitis on PD Posted 02-14-2025
• Tom Oostrom of the Dutch Kidney Foundation Shares NeXtkidney Updates Posted 02-14-2025